Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Product used for evaluating effect of propranolol in treatment of infant hemangioma

A technology of infantile hemangioma and propranolol, applied in the field of medicine, can solve problems such as no breakthrough progress, and achieve a significant effect of rehabilitation

Active Publication Date: 2019-02-26
SHANDONG UNIV QILU HOSPITAL
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In summary, the emergence of PRO provides a certain opportunity for the study of the pathogenesis of IH, but there is still no breakthrough at this stage

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Product used for evaluating effect of propranolol in treatment of infant hemangioma
  • Product used for evaluating effect of propranolol in treatment of infant hemangioma
  • Product used for evaluating effect of propranolol in treatment of infant hemangioma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0043] It should be noted that the following detailed description is exemplary and intended to provide further explanation of the present invention. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

[0044] It should be noted that the terminology used here is only for describing specific embodiments, and is not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly dictates otherwise, the singular is intended to include the plural, and it should also be understood that when the terms "comprising" and / or "comprising" are used in this specification, they mean There are features, steps, operations and / or combinations thereof.

[0045] Aiming at the problems raised in the background technology, the present invention provides a product for evaluating the prognosis of infantile heman...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to View More

Abstract

The invention belongs to medical field, and more specifically relates to a product used for evaluating effect of propranolol in treatment of infant hemangioma. The product is a kit, equipment, an operating system, and / or a composition of the kit, the equipment, and the operating system. The product comprises 1, a reagent, an instrument and / or a system used for measuring expressive abundances of ID1 and beta-actin in cells of a measurement object; 2, a module and / or a processor used for calculating ID1 relative expression quantity; and 3, a module and / or a processor used for evaluation of treatment effect of propranolol on infant hemangioma based on the ID1 relative expression quantity. The product is capable of detecting whether drug resistance of infant patients with hemangioma on propranolol is caused, can be used for effective evaluation on treatment effect of propranolol on infant hemangioma, and is capable of providing an effective evaluation method. The evaluation method possesses important meaning in in-time detecting whether drug resistance of patients on propranolol is caused, and adjusting of treatment schemes.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a product for evaluating the effect of propranolol in treating infantile hemangioma. Background technique [0002] Infantile hemangioma (Infantile Hemangiomas, IH) is a common vascular tumor of infants, the incidence rate of which is as high as 5-10% in ordinary infants, and rises to 30% in premature infants. The onset process is that punctate erythema appears on the skin within a few weeks after delivery, enters a rapid proliferation period, and spontaneously enters a regression period that lasts for several years after about one year of age (Kilcline, C., Frieden, I.J. (2008) Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol. 25(2):168-173; Chang, L.C., Haggstrom, A.N., Drolet, B.A., Baselga, E., Chamlin, S.L., Garzon, M.C., Horii, K.A. , Lucky, A.W., Mancini, A.J., Metry, D.W., Nopper, A.J., Frieden, I.J. (2008) Gro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886A61K31/138A61P35/00
CPCA61K31/138A61P35/00C12Q1/6886C12Q2600/158
Inventor 刘超范招纳赵雯静岳琳琳谈万业张浩魏翔刘少华彭化海宋代辉张东
Owner SHANDONG UNIV QILU HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com